Incidence of Diarrhea Using High and Low Osmolality Enteral Tube Feeding in Critically Ill Surgical Patients
NCT ID: NCT03487744
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
60 participants
INTERVENTIONAL
2018-07-02
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings
NCT01448135
Once Versus Twice Daily Electrolyte Monitoring in CHF
NCT02497742
Comparison Between Two Concentration of Hypertonic Saline in Intestinal Obstruction Surgery
NCT03741257
Fluid Balance Neutralization During CRRT (Continuous Renal Replacement Therapy)
NCT04801784
Evaluating Ileostomy Hydration Protocol
NCT04669964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Promote without fiber
Lower osmolality enteral tube feed formulation
Promote without fiber
Continuous enteral tube feeding according to a standardized calculation via nasojejunal tube.
Osmolite 1.5
Higher osmolality enteral tube feed formulation
Osmolite 1.5
Continuous enteral tube feeding according to a standardized calculation via nasojejunal tube.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osmolite 1.5
Continuous enteral tube feeding according to a standardized calculation via nasojejunal tube.
Promote without fiber
Continuous enteral tube feeding according to a standardized calculation via nasojejunal tube.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to SICU or CVICU requiring TF for enteral nutrition
* anticipated ICU stay and TF requirement \>72 hours
Exclusion Criteria
* Inability to tolerate at least 75% of estimated requirement by day 3 of enteral TF administration
* Clostridium difficile infection or other cause of infectious diarrhea prior to study enrollment
* Presence of an ileostomy or colostomy
* History of inflammatory bowel disease, bowel resection, short gut syndrome, or chronic diarrhea
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amanda Zomp
Clinical Pharmacist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah Health
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB_00108798
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.